Using a handheld ultrasound device for pregnancy follow-up in Senegal
Performance of the Echopen Probe in Its Clinical Use for Pregnancy Follow-up in Senegal
This study tests whether a handheld ultrasound device can help midwives in Senegal monitor pregnancies better than regular ultrasounds, especially in areas with fewer resources.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 224 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | echOpen Factory Industry-sponsored |
| Locations | 2 sites (Karang, Fatick Region and 1 other locations) |
| Trial ID | NCT05765539 on ClinicalTrials.gov |
What this trial studies
This study evaluates the echOpen O1 ultrasound probe's effectiveness in monitoring pregnancies in Senegal, particularly in resource-limited settings. The probe is designed to provide non-invasive imaging during clinical examinations, allowing midwives to identify potential complications. The study compares the performance of this portable device to standard ultrasound examinations in urban and rural health centers. It aims to assess the feasibility, usability, and impact on women's quality of life during pregnancy.
Who should consider this trial
Good fit: Ideal candidates are pregnant women aged 18 and older, at least 37 weeks along in their pregnancy, and planning to deliver at the recruitment center.
Not a fit: Patients with known fetal abnormalities or those experiencing emergencies during management may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance pregnancy monitoring and improve outcomes for mothers and infants in low-resource settings.
How similar studies have performed: While the use of portable ultrasound devices is gaining traction, this specific application in a low-resource setting is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnancy ≥ 37 weeks of amenorrhea * Women aged ≥ 18 years old * Delivery scheduled to take place in the recruitment center * Have given her written informed consent to participate Exclusion Criteria: * Known fetal morphological abnormality * Emergency context during the participant's management * Obstetrical work in progress * Women anticipating displacement or no delivery at the clinical site
Where this trial is running
Karang, Fatick Region and 1 other locations
- Poste de Santé de Karang — Karang, Fatick Region, Senegal (Recruiting)
- Centre de Santé de Sokone — Sokone, Fatick Region, Senegal (Recruiting)
Study contacts
- Principal investigator: Fatoumata D. Sarr, M.D., MPH — Institut Pasteur de Dakar
- Study coordinator: Jose F. Fernandes, M.D., Ph.D.
- Email: josefernandes@echopenfactory.com
- Phone: +33671135665
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.